These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23839331)

  • 21. Case report: The efficacy and safety of lomitapide in a homozygous familial hypercholesterolemic child.
    Chacra APM; Ferrari MC; Rocha VZ; Santos RD
    J Clin Lipidol; 2019; 13(3):397-401. PubMed ID: 30948303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LOWER, a registry of lomitapide-treated patients with homozygous familial hypercholesterolemia: Rationale and design.
    Blom DJ; Fayad ZA; Kastelein JJ; Larrey D; Makris L; Schwamlein C; Bloeden L; Underberg J;
    J Clin Lipidol; 2016; 10(2):273-82. PubMed ID: 27055957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of homozygous familial hypercholesterolaemia in two brothers.
    Real J; Arbona C; Goterris R; Ascaso JF
    BMJ Case Rep; 2018 Jan; 2018():. PubMed ID: 29306853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lomitapide: A novel agent for the treatment of homozygous familial hypercholesterolemia.
    Davis KA; Miyares MA
    Am J Health Syst Pharm; 2014 Jun; 71(12):1001-8. PubMed ID: 24865757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emerging low-density lipoprotein therapies: Microsomal triglyceride transfer protein inhibitors.
    Goldberg AC
    J Clin Lipidol; 2013; 7(3 Suppl):S16-20. PubMed ID: 23642324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Familial hypercholesterolaemia: new treatment options.
    Ezzahti M; Sijbrands EJ; Mulder MT; Roeters van Lennep JE
    Neth J Med; 2013 Jun; 71(5):227-33. PubMed ID: 23799308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Homozygous familial hypercholesterolaemia: metabolic studies and treatment with LDL apheresis.
    Mol MJ; Stalenhoef AF
    Neth J Med; 1990 Jun; 36(5-6):279-87. PubMed ID: 2395495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term efficacy of lipoprotein apheresis in homozygous familial hypercholesterolaemia.
    Meier P; Blanc E
    Nephrol Dial Transplant; 2000 May; 15(5):738-40. PubMed ID: 10809830
    [No Abstract]   [Full Text] [Related]  

  • 29. Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia.
    Cuchel M; Bloedon LT; Szapary PO; Kolansky DM; Wolfe ML; Sarkis A; Millar JS; Ikewaki K; Siegelman ES; Gregg RE; Rader DJ
    N Engl J Med; 2007 Jan; 356(2):148-56. PubMed ID: 17215532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Familial hypercholesterolemia].
    Turpin G; Bruckert E
    Ann Med Interne (Paris); 1999 Dec; 150(8):605-14. PubMed ID: 10686642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Normal levels of lipoproteins including lipoprotein(a) after liver-heart transplantation in a patient with homozygous familial hypercholesterolaemia.
    Barbir M; Khaghani A; Kehely A; Tan KC; Mitchell A; Thompson GR; Yacoub M
    Q J Med; 1992; 85(307-308):807-12. PubMed ID: 1484944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Familial hypercholesterolaemia: optimum treatment strategies.
    Ballantyne CM
    Int J Clin Pract Suppl; 2002 Jul; (130):22-6. PubMed ID: 12296605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Familial hypercholesterolemia in children and adolescents.
    McCrindle BW
    Curr Opin Lipidol; 2012 Dec; 23(6):525-31. PubMed ID: 22914663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dietary Intake during 56 Weeks of a Low-Fat Diet for Lomitapide Treatment in Japanese Patients with Homozygous Familial Hypercholesterolemia.
    Kameyama N; Maruyama C; Kitagawa F; Nishii K; Uenomachi K; Katayama Y; Koga H; Chikamoto N; Kuwata Y; Torigoe J; Arimoto M; Tokumaru T; Ikewaki K; Nohara A; Otsubo Y; Yanagi K; Yoshida M; Harada-Shiba M
    J Atheroscler Thromb; 2019 Jan; 26(1):72-83. PubMed ID: 29899183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is mipomersen ready for clinical implementation? A transatlantic dilemma.
    Sjouke B; Balak DM; Beuers U; Ratziu V; Stroes ES
    Curr Opin Lipidol; 2013 Aug; 24(4):301-6. PubMed ID: 23759796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The diagnosis and management of familial hypercholesterolaemia.
    Marais AD; Firth JC
    Eur Rev Med Pharmacol Sci; 2005; 9(3):141-9. PubMed ID: 16080633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early diagnosis and treatment of familial hypercholesterolemia: improving patient outcomes.
    Alonso R; Mata P; Zambón D; Mata N; Fuentes-Jiménez F
    Expert Rev Cardiovasc Ther; 2013 Mar; 11(3):327-42. PubMed ID: 23469913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mipomersen, an antisense apolipoprotein B synthesis inhibitor.
    Bell DA; Hooper AJ; Burnett JR
    Expert Opin Investig Drugs; 2011 Feb; 20(2):265-72. PubMed ID: 21210756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lomitapide, a microsomal triglyceride transfer protein inhibitor for the treatment of hypercholesterolemia.
    Rizzo M
    IDrugs; 2010 Feb; 13(2):103-11. PubMed ID: 20127562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term effects of LDL apheresis in patients with severe hypercholesterolemia.
    Sachais BS; Katz J; Ross J; Rader DJ
    J Clin Apher; 2005 Dec; 20(4):252-5. PubMed ID: 15880364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.